Currently, there are 432.52M common shares owned by the public and among those 431.95M shares have been available to trade.
The top 3 mutual fund holders in Cameco Corp. are Global X Uranium ETF, American Funds Capital World Grow, and Fidelity Canadian Growth Company. Global X Uranium ETF owns 13.45 million shares of the company’s stock, all valued at over $617.68 million. American Funds Capital World Grow sold 8699.0 shares to see its total holdings shrink to 11.44 million shares valued at over $525.2 million and representing 2.64% of the shares outstanding. Fidelity Canadian Growth Company bought 0.59 million shares to bring its total holdings to over 7.55 million shares at a value of $346.78 million. Fidelity Canadian Growth Company now owns shares totaling to 1.74% of the shares outstanding.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The company’s stock has a 5-day price change of -4.68% and 10.81% over the past three months. CCJ shares are trading 93.07% year to date (YTD), with the 12-month market performance up to 101.61% higher. It has a 12-month low price of $21.22 and touched a high of $46.95 over the same period. CCJ has an average intraday trading volume of 5.26 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.42%, 4.04%, and 29.32% respectively.
Institutional ownership of Cameco Corp. (NYSE: CCJ) shares accounts for 77.09% of the company’s 432.52M shares outstanding. Mutual fund holders own –, while other institutional holders and individual stakeholders account for — and — respectively.
It has a market capitalization of $18.99B and a beta (3y monthly) value of 0.96. The stock’s trailing 12-month PE ratio is 96.56, while the earnings-per-share (ttm) stands at $0.45. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.03% over the week and 3.18% over the month.
Analysts forecast that Cameco Corp. (CCJ) will achieve an EPS of $0.14 for the current quarter, $0.23 for the next quarter and $1.1 for 2024. The lowest estimate earnings-per-share for the quarter is $0.06 while analysts give the company a high EPS estimate of $0.31. Comparatively, EPS for the current quarter was $0.07 a year ago. Earnings per share for the fiscal year are expected to increase by 158.13%, and 111.05% over the next financial year.
